Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 6/20 | 0.36 |
| ▸ | HTR2A | P28223 | 6/20 | 0.36 |
| ▸ | DRD3 | P35462 | 6/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4971329 | 0.89 | MME (0.37) | MEN1KMT2ADRD2HTR2ADRD3 | |
| SCHEMBL4968981 | 0.83 | ALDH1A1 (0.39) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4969728 | 0.83 | KMT2A (0.39) | MEN1KMT2ATSHRLMNAPKM | |
| SCHEMBL4970042 | 0.82 | KMT2A (0.38) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4970216 | 0.82 | ALDH1A1 (0.40) | MEN1KMT2ADRD2HTR2ADRD3 | |
| SCHEMBL4973945 | 0.82 | RAB9A (0.40) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4969574 | 0.80 | ALDH1A1 (0.36) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4969112 | 0.78 | MME (0.38) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4969242 | 0.78 | KDM4E (0.43) | MEN1KMT2ATSHRALDH1A1KDM4E | |
| SCHEMBL4970321 | 0.78 | MEN1 (0.50) | MEN1KMT2ATSHRLMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1985297-A1 | CARBOXYLIC ACID COMPOUND AND USE THEREOF | Japan Tobacco, Inc. (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | JAPAN TOBACCO INC. (JP) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197512-A1 | Carboxylic Acid Compounds and Use Thereof | GLS, SLC10A1, SOAT1 | MEN1 4288/4885KMT2A 1121/4885DRD2 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.